Entry Detail



General Information

Database ID:exR0016310
RNA Name:YWHAE
RNA Type:mRNA
Chromosome:chr17
Starnd:-
Coordinate:
Start Site(bp):1344275End Site(bp):1400222
External Links:ENSG00000108953



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AKR1B1
chr7
134442356
134459284
-
ADO
chr10
62804720
62808479
+
ADAR
chr1
154582057
154628013
-
AC069368.1
chr15
64841883
64930920
+
ACAT2
chr6
159762045
159779112
+
AJUBA
chr14
22971177
22982551
-
AEN
chr15
88621337
88632281
+
ABCC1
chr16
15949577
16143074
+
ACTG1
chr17
81509971
81523847
-
AC104452.1
chr3
49416777
49429314
-
AC015813.2
chr17
57989038
58007246
-
ADH5
chr4
99070978
99088801
-
ACADSB
chr10
123008979
123058290
+
AFDN
chr6
167826922
167972023
+
AJAP1
chr1
4654609
4792534
+
ADM2
chr22
50481543
50486440
+
ABRACL
chr6
139028745
139043302
+
ACTB
chr7
5527148
5563784
-
AKAP13
chr15
85380571
85749358
+
AL590132.1
chr1
210858125
211134146
-
ACLY
chr17
41866917
41930542
-
AHSA1
chr14
77457870
77469472
+
ADCY2
chr5
7396138
7830081
+
ALDOA
chr16
30064164
30070457
+
ALDH9A1
chr1
165662216
165698863
-
AKAP9
chr7
91940867
92110673
+
AGPAT1
chr6
32168212
32178096
-
ACTR1A
chr10
102461881
102502712
-
AC092073.1
chr19
34396315
34409364
+
AC010463.1
chr19
17267418
17282966
+
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-let-7b-5p
chr22
46113691
46113712
+
hsa-miR-423-5p
chr17
30117095
30117117
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC008969.1
chr19
58002061
58011232
+
AC010615.2
chr19
21444241
21463908
-
AC020663.1
chr16
4730115
4752565
-
AC026362.1
chr12
122975320
122982907
+
AC040162.3
chr16
67882461
67886367
+
AC106864.1
chr4
112693047
112706810
-
AC125807.2
chr12
3041437
3044950
+
AC132217.1
chr11
2129121
2129964
-
AC139149.1
chr17
81514047
81527776
+
AC145207.5
chr17
81878425
81881106
-
AD000090.1
chr19
35557956
35581954
+
AL022311.1
chr22
37876148
37895563
+
AL117378.1
chr6
131901963
131920565
+
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.